Rapid Micro BiosystemsRPID +0.59%60 Days Payable is 52.67 as of Mar. 2026, which is 6% above its 10-year median of 49.57. GuruFocus rates RPID with a GF Score™ of 60/100 and a GF Value™ of $1.88 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Rapid Micro Biosystems ranks worse than 75.75% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Rapid Micro Biosystems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapid Micro Biosystems Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's Days Payable distribution charts can be found below:
* The bar in red indicates where Rapid Micro Biosystems's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Rapid Micro Biosystems's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Micro Biosystems (RPID) has a Days Payable of 52.67 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rapid Micro Biosystems and its competitors. This is near median its historical median of 49.57. Over the past decade, Rapid Micro Biosystems' Days Payable has ranged from 29.22 to 69.99. According to the industry distribution chart, Rapid Micro Biosystems ranks #603 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 75.8%.
Is Rapid Micro Biosystems' Days Payable too high?
Rapid Micro Biosystems' current Days Payable of 52.67 is near median its 10-year median of 49.57. Over the past 10 years, this metric has ranged from a low of 29.22 to a high of 69.99. The Medical Devices & Instruments industry median Days Payable is 68.14. Rapid Micro Biosystems' value of 52.67 is 22.7% below this industry median. Based on the distribution chart, Rapid Micro Biosystems ranks #603 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rapid Micro Biosystems has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rapid Micro Biosystems' Days Payable compare to OM and NNOX?
According to the Medical Devices & Instruments industry distribution chart, Rapid Micro Biosystems ranks #603 out of 796 companies for Days Payable. This places Rapid Micro Biosystems in the lower half of its industry. The industry median Days Payable is 68.14. Rapid Micro Biosystems' value of 52.67 is 22.7% below this benchmark. Historically, Rapid Micro Biosystems' own Days Payable has ranged from 29.22 to 69.99 over the past decade. While the company's 10-year median is 49.57 vs. the industry median of 68.14, Rapid Micro Biosystems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rapid Micro Biosystems's current Days Payable of 52.67 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rapid Micro Biosystems and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Micro Biosystems's current Days Payable is 52.67, which is near median its own 10-year median of 49.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Micro Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Rapid Micro Biosystems (RPID) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.88, compared to a current price of $1.70 — trading 9.6% below its estimated fair value. The current Days Payable is 52.67, which is near median its 10-year median of 49.57 and 22.7% below the Medical Devices & Instruments industry median of 68.14. Rapid Micro Biosystems' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Rapid Micro Biosystems (RPID), the current Days Payable is 52.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rapid Micro Biosystems (RPID) Overvalued in 2026?
Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be undervalued.
The current stock price of $1.70 is trading 9.6% below its estimated GF Value™ of $1.88.
GuruFocus considers Rapid Micro Biosystems to be Modestly Undervalued.
Key valuation signals for RPID:
Days Payable: 52.67 (near median its 10-year median of 49.57)
GF Value™: $1.88 vs. price of $1.70 (9.6% below fair value)
Industry Position: 22.7% below the Medical Devices & Instruments median (#603 of 796)
No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
60GF Score
Get the complete analysis for RPID
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RPID has been successfully added to your 
